111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-113.82%
Negative net income growth while CX stands at 138.08%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-6.47%
Both reduce yoy D&A, with CX at -0.63%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
120.48%
Deferred tax of 120.48% while CX is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
4.92%
SBC growth while CX is negative at -100.00%. John Neff would see competitor possibly controlling share issuance more tightly.
-197.77%
Both reduce yoy usage, with CX at -339.75%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-119.07%
Both yoy AR lines negative, with CX at -201.34%. Martin Whitman would suspect an overall sector lean approach or softer demand.
22.35%
Some inventory rise while CX is negative at -262.77%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
-1036.49%
Negative yoy usage while CX is 43.86%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-78.51%
Both negative yoy, with CX at -112.93%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-124.14%
Both yoy CFO lines are negative, with CX at -112.04%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
27.54%
CapEx growth well above CX's 47.18%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-1120.00%
Negative yoy acquisition while CX stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
100.00%
Purchases growth of 100.00% while CX is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
No Data
No Data available this quarter, please select a different quarter.
123.39%
We have some outflow growth while CX is negative at -100.05%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
48.89%
Investing outflow well above CX's 60.09%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
172.79%
We repay more while CX is negative at -102.32%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-79.42%
Negative yoy issuance while CX is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-20.16%
We cut yoy buybacks while CX is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.